149 related articles for article (PubMed ID: 17139647)
1. Pulmonary sarcoidosis developing during infliximab therapy.
O'Shea FD; Marras TK; Inman RD
Arthritis Rheum; 2006 Dec; 55(6):978-81. PubMed ID: 17139647
[No Abstract] [Full Text] [Related]
2. Pulmonary sarcoidosis in a patient with psoriatic arthritis during infliximab therapy.
Izzi S; Francesconi F; Visca P; Altieri A; De Mutiis C; Trevisan G; Bonifati C
Dermatol Online J; 2010 May; 16(5):16. PubMed ID: 20492833
[TBL] [Abstract][Full Text] [Related]
3. Infliximab induced skin and pulmonary sarcoidosis in a rheumatoid arthritis patient.
Josse S; Klemmer N; Moreno-Swirc S; Goëb V; Lequerré T; Vittecoq O
Joint Bone Spine; 2009 Dec; 76(6):718-9. PubMed ID: 19464223
[No Abstract] [Full Text] [Related]
4. Sarcoidosis and tocilizumab: is there a link?
Bustamente L; Buscot M; Marquette CH; Roux C
Clin Exp Rheumatol; 2017; 35(4):716. PubMed ID: 28516883
[No Abstract] [Full Text] [Related]
5. Pulmonary sarcoidosis in a patient with ankylosing spondylitis treated with infliximab.
Almodóvar R; Izquierdo M; Zarco P; Javier Quirós F; Mazzucchelli R; Steen B
Clin Exp Rheumatol; 2007; 25(1):99-101. PubMed ID: 17417999
[TBL] [Abstract][Full Text] [Related]
6. Development of sarcoidosis during etanercept therapy.
Ishiguro T; Takayanagi N; Kurashima K; Matsushita A; Harasawa K; Yoneda K; Tsuchiya N; Miyahara Y; Yamaguchi S; Yano R; Tokunaga D; Saito H; Ubukata M; Yanagisawa T; Sugita Y; Kawabata Y
Intern Med; 2008; 47(11):1021-5. PubMed ID: 18520114
[TBL] [Abstract][Full Text] [Related]
7. [Pulmonary and renal involvement in a TNFα antagonist drug-induced sarcoidosis].
Olivier A; Gilson B; Lafontaine S; Pautot JX; Bindi P
Rev Med Interne; 2012 May; 33(5):e25-7. PubMed ID: 21592629
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor-alpha antagonist-induced sarcoidosis.
Clementine RR; Lyman J; Zakem J; Mallepalli J; Lindsey S; Quinet R
J Clin Rheumatol; 2010 Sep; 16(6):274-9. PubMed ID: 20808167
[TBL] [Abstract][Full Text] [Related]
9. Lung sarcoidosis induced by TNF antagonists in rheumatoid arthritis: a case presentation and a literature review.
Gifre L; Ruiz-Esquide V; Xaubet A; Gómez-Puerta JA; Hernández MV; Sanmartí R
Arch Bronconeumol; 2011 Apr; 47(4):208-12. PubMed ID: 20638761
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary complications of infliximab therapy in patients with rheumatoid arthritis.
Ostör AJ; Chilvers ER; Somerville MF; Lim AY; Lane SE; Crisp AJ; Scott DG
J Rheumatol; 2006 Mar; 33(3):622-8. PubMed ID: 16511933
[TBL] [Abstract][Full Text] [Related]
11. Development of leprosy and type 1 leprosy reactions after treatment with infliximab: a report of 2 cases.
Scollard DM; Joyce MP; Gillis TP
Clin Infect Dis; 2006 Jul; 43(2):e19-22. PubMed ID: 16779736
[TBL] [Abstract][Full Text] [Related]
12. Development of interstitial pneumonia in a rheumatoid arthritis patient treated with infliximab, an anti-tumor necrosis factor alpha-neutralizing antibody.
Mori S; Imamura F; Kiyofuji C; Sugimoto M
Mod Rheumatol; 2006; 16(4):251-5. PubMed ID: 16906378
[TBL] [Abstract][Full Text] [Related]
13. Development of pulmonary and cardiac sarcoidosis during etanercept therapy.
Miyagi R; Ideguchi H; Soga T; Yamakawa Y; Otsuki H; Niino H; Shiina T; Ueda A; Ishigatsubo Y
Int J Rheum Dis; 2014 Sep; 17(7):810-2. PubMed ID: 24460777
[No Abstract] [Full Text] [Related]
14. Comment on: Sarcoid-like granulomatosis in patients treated with tumour necrosis factor blockers: 10 cases.
Massara A; Cavazzini L; La Corte R; Trotta F
Rheumatology (Oxford); 2010 May; 49(5):1019-21; author reply 1021-2. PubMed ID: 20056768
[No Abstract] [Full Text] [Related]
15. Pyoderma gangrenosum developing during therapy with TNF-alpha antagonists in a patient with rheumatoid arthritis.
Vandevyvere K; Luyten FP; Verschueren P; Lories R; Segaert S; Westhovens R
Clin Rheumatol; 2007 Dec; 26(12):2205-2206. PubMed ID: 17876646
[No Abstract] [Full Text] [Related]
16. Polymyositis associated with infliximab treatment for rheumatoid arthritis.
Urata Y; Wakai Y; Kowatari K; Nitobe T; Mizushima Y
Mod Rheumatol; 2006; 16(6):410-1. PubMed ID: 17165006
[No Abstract] [Full Text] [Related]
17. Risk of serious infections and malignancies with anti-TNF antibody therapy in rheumatoid arthritis.
Hochman D; Wolff B
JAMA; 2006 Nov; 296(18):2203; author reply 2203-4. PubMed ID: 17090763
[No Abstract] [Full Text] [Related]
18. Risk of serious infections and malignancies with anti-TNF antibody therapy in rheumatoid arthritis.
Callegari PE; Schaible TF; Boscia JA
JAMA; 2006 Nov; 296(18):2202; author reply 2203-4. PubMed ID: 17090762
[No Abstract] [Full Text] [Related]
19. Risk of serious infections and malignancies with anti-TNF antibody therapy in rheumatoid arthritis.
Costenbader KH; Glass R; Cui J; Shadick N
JAMA; 2006 Nov; 296(18):2201; author reply 2203-4. PubMed ID: 17090761
[No Abstract] [Full Text] [Related]
20. Sarcoidosis during anti-tumor necrosis factor-alpha therapy: no relapse after rechallenge.
van der Stoep D; Braunstahl GJ; van Zeben J; Wouters J
J Rheumatol; 2009 Dec; 36(12):2847-8. PubMed ID: 19966199
[No Abstract] [Full Text] [Related]
[Next] [New Search]